US Patent Issued to Boehringer Ingelheim International on Feb. 3 for "Method of treating vascular eye and retinal diseases by administration of anti-Neuropilin 1A antibodies" (American, German Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,540,187, issued on Feb. 3, was assigned to Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany).

"Method of treating vascular eye and retinal diseases by administration of anti-Neuropilin 1A antibodies" was invented by Nina Zippel (Biberach an der Riss, Germany), Pankaj Gupta (Scarsdale, N.Y.), Fei Han (Acton, Mass.), Yining Huang (Belmont, Mass.), Sarah Low (Carmel, N.Y.), Juergen Prestle (Biberach an der Riss, Germany) and Leo Thomas (Biberach an der Riss, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are antibodies and fragments thereof that target the A-domain of Neuropilin-1 (Nrp1A). Also disclosed are methods of ...